Ovid Therapeutics
A biotechnology company specializing in creating therapeutics for neurological disorders. It was founded in 2014 and is located in New York City.
3
Funding Rounds
$106.0m
Money raised
Overview
A biotechnology company specializing in creating therapeutics for neurological disorders. It was founded in 2014 and is located in New York City.
-
Website:
- Business model: B2B UNKNOWN B2C
- Social accounts:
| Name | Phone | Social networks | |
|---|---|---|---|
| Ma J. Du**** | - | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| Ba** Fr* | - | - | - |
| Je**** Le*** | - | - | - |
| Ba Du**** | - | - | - |
Funding
Funding series
Funding Series Analysis
The company Ovid Therapeutics has raised a total of $105.96m in funding over 3 rounds.
Key Insights:
- Ovid Therapeutics Series C round, 2017: $25.86m
- Ovid Therapeutics Series B round, August 2015: $75m
- Ovid Therapeutics Venture round, March 2015: $5.1m
Ovid Therapeutics Series C round, 2017
$25.86m
Ovid Therapeutics Series B round, August 2015
$75m
Ovid Therapeutics Venture round, March 2015
$5.1m
Industries
Ovid Therapeutics is active in the following industries: